Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
123 results about "Angina pain" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Chest pain caused by coronary heart disease
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
ActiveUS20080220092A1Improve performanceReduce the amount requiredHeavy metal active ingredientsBiocidePhytochemicalAntioxidant
Systems and methods for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and treating hyperglycemia, Alzheimer's disease, sleep disorders, Parkinson's disease, Attention Deficit Disorder and nicotine addiction involve synchronizing and tailoring the administration of nutraceuticals, medications and other substances (for example, stimulants) in accordance with the body's natural circadian rhythms, meal times and other factors. Improved control of blood glucose levels, extended alertness, and weight control, and counteracting of disease symptoms when they are at their worst are possible. An automated, pre-programmable transdermal administration system is used to provide pulsed doses of medications, pharmaceuticals, hormones, neuropeptides, anorexigens, pro-drugs, stimulants, plant extracts, botanicals, nutraceuticals, cosmeceuticals, phytochemicals, phytonutrients, enzymes, antioxidants, essential oils, fatty acids, minerals, vitamins, amino acids, coenzymes, or other physiological active ingredient or precursor. The system can utilize a pump, pressurized reservoir, a system for removing depleted carrier solution, or other modulated dispensing actuator, in conjunction with porous membranes or micro-fabricated structures.
Owner:MORNINGSIDE VENTURE INVESTMENTS
Neurostimulation and coronary artery disease treatment
InactiveUS20080021503A1Improve efficiencyElectrocardiographyInternal electrodesDiseaseCoronary artery disease
A method for treating a patient may include treating coronary artery disease in combination with angina pectoris and / or the control of angina pain by delivering chemical and / or electrical stimulation pulses to the cardiac and / or nervous tissue of the patient in a coordinated manner. A system for treating a patient suffering from coronary artery disease and angina may include a stimulator that generates at least one pulse in accordance with prescribed parameters, a catheter, a lead, and / or a sensor.
Owner:CARDIAC PACEMAKERS INC
Quality control method of the Yixinshu Chinese traditional medicine for supplementing qi and for promoting blood circulation by removing blood stasis
The invention relates to a quality control method of Yixinshu traditional chinese medicine preparation for nourishing qi, restoring pulse, and activating blood circulation to dissipate blood stasis, belonging to medicine domain. The Yixinshu traditional chinese medicine preparation is composed of panax, astragalus root, radix salviae miltiorrhizae, lityturf root, chinese magnoliaving, chuanxiong rhizome and haw, with ability of nourishing qi, restoring pulse, activating blood circulation to dissipate blood stasis, nourishing yin and production of body fluid, applicable for the patients who suffer for deficiency of both vital energu and yin, heart-throb knotted pulse, chest oppression, chest pain, and angina pectoris of coronary heart disease. At present, on clinical usage, it is applied extensively in the treatment of angina pectoris, myocardial ischemia, various type of arrhythmias, atrial premature beat, chest pain, angina pectoris of coronary heart disease and so on. The said quality control method provides the criterion of detection, means of detection, technical method and so on for the associated production and detection mechanism, therefore the quality of Yixinshu traditional chinese medicine preparation can be better controlled to ensure the safety of the said preparation. The quality method can better guide the production to make the production process control more strict and reasonable, therefore the users could have an overall acquaintance with the product quality.
Owner:GUIZHOU XINBANG PHARMACEUTICAL CO LTD
Drug for treating coronary heart disease, angina and preparation method
ActiveCN1539474AInhibit the formation of thrombusReduces cardiac afterloadPharmaceutical delivery mechanismUnknown materialsCoronary heart diseaseAngina
Owner:山东宏济堂制药集团股份有限公司
Process of extracting puerariae and making food and medicine addied with it
InactiveCN1560062AInhibit peroxidationAntioxidantSugar derivativesAlcoholic beverage preparationThirstCoronary heart disease
The invention relates to an effective method of extracting puerarin and green food medicines made by it, and the steps include: using alcohol to soak, extracting several times, evaporating the alcohol, converting the extract into water solution, filtering out suspended substances; adopting polymeric absorbent to absorb, concentrating and drying and obtaining Gegen extract, by absorbing and eluting, further making flavone glycoside and terpene inner ester reach the specified indexes. Putting the extracted puerarin in drinks, beers, distilled spirits, teas, milk powders, etc; or adding the puerarin in the tablets, capsules, and electuaries or injectas. The pure plant natural food has proper taste. The Gegen is moderate, peppery and sweet, disperses the internal coldness and relieves the heat of muscle, promotes blood circulation, quenching the thirst and detoxicates alcohol toxicity, etc. and it has good curing effect on high blood pressure, coronary heart disease, heartstroke, dispels the wind, etc.
Owner:白栓锁
Medicine compounds capable of regulating hypertension, hyperlipemia and angina
InactiveCN101229312AAlleviate the conditionLower blood pressureMetabolism disorderSolution deliveryAnginaSpleen
The invention discloses a medicine combination of adjusting hypertension, hyperlipidemia and angina, consisting of astragalus, panax, salvia, cynostemma, americanwater plantain, ginkgo biloba, panax notoginseng, hawthorn, mythic fungus, schisandra, fragrant solomonseal rhizome and wolfberry fruit. The medicine combination of the invention has the advantages of invigorating qi and replenishing yin, activating blood and stabilizing pain, nourishing heart and calming mind, replenishing qi and nourishing blood, supplementing spleen and invigorating kidney, promoting moisture and urination, clearing heat, detoxifying and cooling blood, reducing tension, clearing liver, reducing lipid, nourishing yin, improving eyesight, reinforcing kidney, reducing sugar, dual directionally regulating and etc. Meanwhile, the medicine has an obvious effect on treating hypertension, hyperlipidemia, angina, and the hypertensions and anginas caused by unknown reasons.
Owner:凌泰祥
Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
The present invention relates to amide derivatives of Formula (XIIIa) and pharmaceutical compositions thereof that modulate the activity of the PGI2 receptor. Compounds of the present invention and pharmaceutical compositions thereof are directed to methods useful in the treatment of: pulmonary arterial hypertension (PAH); idiopathic PAH; familial PAH; PAH associated with a collagen vascular disease, a congenital heart disease, portal hypertension, HIV infection, ingestion of a drug or toxin, hereditary hemorrhagic telangiectasia, splenectomy, pulmonary veno-occlusive disease (PVOD) or pulmonary capillary hemangiomatosis (PCH); PAH with significant venous or capillary involvement; platelet aggregation; coronary artery disease; myocardial infarction; transient ischemic attack; angina; stroke; ischemia-reperfusion injury; restenosis; atrial fibrillation; blood clot formation in an angioplasty or coronary bypass surgery individual or in an individual suffering from atrial fibrillation; atherosclerosis; atherothrombosis; asthma or a symptom thereof; a diabetic-related disorder such as diabetic peripheral neuropathy, diabetic nephropathy or diabetic retinopathy; glaucoma or other disease of the eye with abnormal intraocular pressure; hypertension; inflammation; psoriasis; psoriatic arthritis; rheumatoid arthritis; Crohn's disease; transplant rejection; multiple sclerosis; systemic lupus erythematosus (SLE); ulcerative colitis; ischemia-reperfusion injury; restenosis; atherosclerosis; acne; type 1 diabetes; type 2 diabetes; sepsis; and chronic obstructive pulmonary disorder (COPD).
Owner:ARENA PHARMA
Neurostimulation and coronary artery disease treatment
InactiveUS8934968B2Improve efficiencyElectrocardiographyMedical devicesCoronary artery diseaseAngina pain
A method for treating a patient may include treating coronary artery disease in combination with angina pectoris and / or the control of angina pain by delivering chemical and / or electrical stimulation pulses to the cardiac and / or nervous tissue of the patient in a coordinated manner. A system for treating a patient suffering from coronary artery disease and angina may include a stimulator that generates at least one pulse in accordance with prescribed parameters, a catheter, a lead, and / or a sensor.
Owner:CARDIAC PACEMAKERS INC
Method for treatment of unstable coronary artery disease by an early revascularisation together with administration of a low molecular weight heparin
InactiveUS6258798B1Reduce riskPromote resultsOrganic active ingredientsCardiovascular disorderDiseaseCoronary artery disease
The invention relates to a method for treatment of unstable coronary artery disease, which is characterised by an early revascularisation together with administration of a low molecular weight heparin. Preferably the low molecular weight heparin is administered up to revascularisation. The methods are also useful for treatment of unstable angina and not worsening chest pain and for treatment of non-Q-wave myocardial infarction (mild heart attack).
Owner:PHARMACIA AB
Method of preparing quick-acting jiuxin orally disintegrating tablet through 3D printing
ActiveCN105362320AWork quicklyTake fastAdditive manufacturing apparatusHydroxy compound active ingredientsOrally disintegrating tabletComputer printing
The invention provides a method of preparing a quick-acting jiuxin orally disintegrating tablet through 3D printing. The disintegrating tablet is formed by spraying a bonder through a nozzle of a 3D printer to bond medicinal powder, the medicinal powder comprises, by mass, 76-85% of, 12-18% of and 2-6% of, and 3D printing parameters include spraying radius of 2.5-10mm, spraying layer height of 0.1-0.5mm and spraying layer number of 10-50 layers. Heating is not needed in the preparation process, so that loss of active ingredients, such as borneol, which are unstable when being heated in conventional preparation methods is avoided; the disintegrating tablet prepared is high in medicine release speed, content of active ingredients meets requirements of the Chinese Pharmacopoeia, and the disintegrating tablet is especially suitable for acute diseases such as coronary heart disease and angina.
Owner:GUANGDONG PHARMA UNIV
Compound medicine for pulse generating and treating coronary heart disease
InactiveCN101104048AIncrease the variety of clinical drugsMeet clinical needsCardiovascular disorderPlant ingredientsCoronary artery diseaseAngina
The invention belongs to the medication technical field, which discloses the medicine and the preparation method for treating the coronary heart disease and miocardial infarction. The medicine is mainly prepared from ginseng root, dwarf lilyturf tuber, Chinese magnoliavine fruit, radix astragali and Chinese angelica, or ginseng root, dwarf lilyturf tuber, Chinese magnoliavine fruit, radix astragali, Chinese angelica, cassia twig and liquorice, or ginseng root, dwarf lilyturf tuber, Chinese magnoliavine fruit, radix astragali, Chinese angelica, cassia twig, liquorice, danshen root, red peony root, radix notoginseng and safflower, according to certain ratios of weights. The invention can be made to any type of medicament that can be accepted by the clinic or pharmacology, which is the good quality oral preparation. The medicine has effects of Qi-replenishing, Yin-nourishing and pulse-invigorating and blood circulation activating to dissipate blood stasis and lipid lowing, which can be used to curing the chest distress, hard breathe, heart-throb, angina and arrhythmia caused by coronary heart disease and miocardial infarction, the recovery period of the cerebral thrombosis and the sequelae of the cerebral thrombosis, the effects are obvious.
Owner:SHANDONG XUANZHU PHARMA TECH CO LTD
Method for preparing 4-formoxylbenzofuran
Improved, low-cost, scalable process for the preparation of 4-formylbenzofuran starting from 4-methylbenzofuran, wherein the novel 4-dibromobenzofuran is obtained as an intermediate . According to the method of the invention, 4-methylbenzofuran is brominated to obtain novel 4-dibromobenzofuran, which is then hydrolyzed to obtain 4-formylbenzofuran. 4-Formylbenzofura is a key intermediate in the production of isradipine for the treatment of hypertension and angina.
Owner:圣玛精细化工有限责任公司
Persimmon leaf extract preparation, preparing method thereof and application thereof
ActiveCN101744863AGood disintegrationShort disintegration timeNervous disorderPharmaceutical non-active ingredientsSequelaCerebral thrombosis
The present invention provides persimmon leaf extract preparation, a preparing method thereof and application thereof. The persimmon leaf extract preparation comprises the following components: persimmon leaf extract dry paste of 20% to 50 %, dextrine of 10 % to 30%, starch of 20% to 40%, polyvinylpolypyrrolidone of 1% to 10%, sodium carboxymethyl starch of 1% to 10 % and Tween-800 of 1 % to 10%.In the preparing method, the persimmon leaf extract dry paste is mixed with various accessories, which can be pelletized by a wet method (water or ethanol with certain concentration is used as a wetting agent) to be preformed into tablet; or the persimmon leaf extract dry paste is mixed with various accessories to be directly preformed into the tablet in a dry method. The persimmon leaf extract preparation has better disintegration performance, and the disintegration time is shortened; even suspension can be formed; the drug biologic use degree is improved; and the persimmon leaf extract preparation is suitable for curing coronary heart disease, angina, cerebral arteriosclerosis, transient ischemic attacks, cerebral thrombosis sequela, senile dementia and the like.
Owner:GUANGZHOU BAIYUSN HUTCHISON WHAMPOA CHINESE MEDICINE
Siberian ginseng and hawthorn leaf green tea
The invention discloses health protection tea and a preparation method thereof. The health protection tea is prepared from raw materials of the stems and leaves of Siberian ginseng which is a natural plant growing in Changbai Mountain, hawthorn leaves in North China and green tea. The health protection tea is developed on the basis of summarizing the traditional Chinese tea making technology by combining the theory of traditional Chinese medicine with the modern nutriology and applying the traditional Chinese medicine processing technology to the traditional tea making technology. The novel health protection tea not only has nutrition and health protection functions, but also can prevent diseases and treat diseases through adjuvant therapy. The health protection tea not only inherits and develops the color, the fragrance, the taste, the appearance and other good qualities of the traditional tea, but also provides a tea delicacy for prompting health, preventing disease and retarding senility for people in the new period. The health protection tea has the efficacies for tonifying the kidney, invigorating the brain, nourishing the heart, soothing the nerves, removing polydipsia, assisting digestion and reducing blood pressure, and especially can exert important efficacy for the prevention and the adjuvant therapy of coronary heart disease, angina and ischemic cardiovascular and cerebrovascular diseases.
Owner:邵伟
Sustained release preparation for treating hypertention and angina, and preparation method thereof
ActiveCN102973515ANo generationReduce generationOrganic active ingredientsPharmaceutical non-active ingredientsHard CapsuleDrugs preparations
The invention relates to the field of drug preparations, and discloses a preparation method for a metoprolol succinate sustained release preparation, and a preparation method thereof. The method comprises the following steps: firstly, coating solution with well prepared raw materials and auxiliary materials onto blank pellets to form a medicating layer, coating a well prepared swelling layer and a sustained release layer on the medicating layer, and finally filling the coated pellets into hard capsules. The method is simple to operate, short in production period, high in efficiency, low in cost, controllable in process, the pellets are evenly coated, the appearance is round and normal and uniform, the stability is good, and the sustained release preparation is convenient to use and used for fully reducing the drug use frequencies of patients with hypertention and angina.
Owner:KAMP PHARMA
Ginkgo juice extracting method, food and medicine therefrom
InactiveCN1456660AAppropriate tasteAntioxidantMetabolism disorderAlcoholic beverage preparationDiseaseVitamin C
A process for extracting ginkgo juice features that the seeds and leaves of ginkgo are immersed in alcohol. The extracted ginkg juice can be added to beverage, beer, spirit, food, and medicine for playing its medical roles, such as improving immunity and treating loss of memory, hepertension, coronary heart disease, angina pectoris, hyperlipemia, etc.
Owner:白栓锁
Method of preparing jiubiying total saponins and the application thereof
InactiveCN101032534AHigh extraction rateSimple processCardiovascular disorderPlant ingredientsVascular diseaseReflux
The present invention relates to total ovateleaf holly saponin for treating coronary heart disease, angina, apoplexy and other cardiac and cerebral vascular diseases, its medicine composition and extracting process. Ovateleaf holly bark is extracted with alcohol, and the extract is added with water and centrifuged to obtain precipitate and supernatant. The precipitate is alcohol reflux extracted, and the extract is treated through filtering, filtrate concentrating, drying and other steps to obtain the first part of total saponin. The supernatant is treated through concentrating, centrifuging, water washing of the precipitate and drying to obtain the second part of total saponin. These two parts of total saponin are merged to obtain the total ovateleaf holly saponin, which may be added with supplementary material and further treated to obtain various kinds of oral preparations and injection.
Owner:潘书洋 +1
Gelan Xinning soft capsule for treating coronary disease and angina and preparation method thereof
ActiveCN102872227AThe preparation method is simple and controllableShorten the production cycleMetabolism disorderCapsule deliveryCoronary artery diseaseSide effect
The invention provides a Gelan Xinning soft capsule for treating coronary disease and angina and a preparation method of the Gelan Xinning soft capsule. The medicine comprises the following raw materials in parts by weight or is composed of the following raw materials in parts by weight: 4 to 60 parts of radix puerariae general flavones, 1 to 30 parts of fructus crataegi extract, 0.4 to 10 parts of gynostemma pentaphylla general flavones, 5 to 100 parts of soybean oil or salad oil, 0.1 to 3 parts of beewax, 0.4 to 10 parts of hydrogenated palm oil, 0.2 to 5 parts of soyabean lecithin, 0.01 to 0.5 parts of dimeticone, 8 to 150 parts of gelatin, 3 to 80 parts of glycerol, 8 to 150 parts of purified water and 0.01 to 0.8 parts of ethylparaben. The preparation method of the medicine provided by the invention is simple, the processing cost is low, the efficacy is remarkable and the Gelan Xinning soft capsule is free from any toxic and side effects.
Owner:XIAN CHIHO PHARMA
Medicament for treating coronary heart disease and angina and preparation method of granular formulation thereof
InactiveCN101658567ANormal activitySmooth furGranular deliveryCardiovascular disorderSalvia miltiorrhizaCoronary artery disease
Owner:SHAANXI HUALONG PHARMA
Medicine composition for treating cardio-cerebral-vascular diseases and preparation method and application thereof
InactiveCN101757391AMetabolism disorderCardiovascular disorderTreatment effectTrichosanthes kirilowii
The invention discloses a medicine composition for treating cardio-cerebral-vascular diseases and a preparation method and application thereof, belonging to the field of traditional Chinese medicines. The effective component of the medicine composition comprises total sapogenin and total alkaloid extracted from traditional Chinese herb trichosanthes kirilowii Maxim and allium macrostemon. The medicine composition which can be made into proper preparation forms has good treatment effects on coronary disease, angina, arteriosclerosis, chest pain, hyperlipoidemia and the like. The invention also discloses preparation methods of the total sapogenin and the total alkaloid.
Owner:代龙
Prodrug compounds
A compound of formula (Ia) or (Ib), or a pharmaceutically acceptable salt thereof, Wherein Q, R2, Ar, A and R1 are as defined in claim 1. The claimed compounds are gap junction blockers useful for the treatment or prevention of a range of conditions including migraine, epilepsy, non-epileptic seizures, brain injury (including stroke, intracranial haemorrhage and trauma induced), pain, neurodegenerative disease or cardiovascular disease including myocardial infarction, coronary revascularization or angina.
Owner:PROMIMAGEN LTD
Use of CBx cannabinoid receptor modulators as potassium channel modulators
InactiveCN101431994AReduce processReduce seizuresNervous disorderMetabolism disorderAppetite regulationEpilepsy
The invention is directed to the use of at least one CBx modulator wherein the CBx modulator is selected from the group consisting of CB1 agonists; CB2 agonists; CB2 partial agonists; CB2 antagonists; CB2 inverse agonists; and dually acting compounds which are both a CB1 agonist and a CB2 agonist; and mixtures thereof, as KATP channel modulator for the prophylaxis, treatment, delayed progression, delayed onset and / or inhibition of a variety of disease conditions including obesity, diabetes mellitus, metabolic syndrome, syndrome X, insulinoma, familial hyperinsulemic hypoglycemia, male pattern baldness, detrusor hyperreactivity, asthma, neuroprotection, epilepsy, analgesia, cardioprotection, angina, cardioplegia, arrhythmia, coronary spasm, peripheral vascular disease, cerebral vasospasm, appetite regulation, neurodegeneration, pain - including neuropathic pain and chronic pain - and impotence in mammals and humans. The invention further relates to methods of treating, preventing, delaying progression of, delaying onset of and / or inhibiting a variety of disease conditions including obesity, diabetes mellitus, metabolic syndrome, syndrome X, insulinoma, familial hyperinsulemic hypoglycemia, male pattern baldness, detrusor hyperreactivity, asthma, neuroprotection, epilepsy, analgesia, cardioprotection, angina, cardioplegia, arrhythmia, coronary spasm, peripheral vascular disease, cerebral vasospasm, appetite regulation, neurodegeneration, pain - including neuropathic pain and chronic pain - and impotence in mammals and humans comprising administering to a subject in need thereof an effective amount of at least one CBx modulator having KATP channel modulating properties.
Owner:SOLVAY PHARMA GMBH
Externally-applied traditional Chinese medicine preparation for curing cardio-cerebral respiratory circulatory system diseases and preparation method thereof
InactiveCN101601775AEasy to useDefinite curative effectHydroxy compound active ingredientsAerosol deliveryDiseaseSide effect
The invention discloses an externally-applied traditional Chinese medicine preparation for curing cardio-cerebral respiratory circulatory system diseases and a preparation method thereof. The externally-applied traditional Chinese medicine preparation is prepared by selecting 34 traditional Chinese medicines capable of promoting blood and qi circulation, removing obstruction in channels and dredging veins, such as spina gleditsiae, semen momordicae, safflower, and the like and can be made into three preparations, namely, paste, medicine bags and tablets. The medicine preparation has a unique prescription, adopts an external treatment method matched with a traditional Chinese medical acupuncture point theory to cure the cardio-cerebral respiratory circulatory system diseases, has remarkable curative effects on various diseases, such as coronary heart disease angina, psychosis, paroxysmal sleep, Parkinson's disease, epileptics, paroxysmal sleep, encephalatrophy, rhinitis, chronic pharyngitis, laryngitis, asthma, gynecologic diseases, child attention deficient disorder, child bed-wetting disease, and the like. In addition, the medicine preparation has the efficacy of promoting intelligence, restoring consciousness, improving the health and strengthening the body without side effect.
Owner:张庆忠
Yuge powder with functions of weight loss and beauty and preparation method for Yuge powder
InactiveCN102524708AWith weight loss beauty functionLong-term useFood preparationAngina painOrganic chemistry
The invention discloses Yuge powder with functions of weight loss and beauty. The Yuge powder is prepared from the following raw materials in part by weight: 10 to 89 parts of Amorphophalms konjac, 10 to 89 parts of the root of kudzu vine and 1 to 20 parts of mulberry leaf. The invention also discloses a preparation method for the Yuge powder. The preparation method comprises the steps of preparation of Pueraria flavone, preparation of Amorphophalms konjac fine powder, preparation of mulberry leaf powder and preparation of the Yuge powder. The formula of the Yuge powder is unique, and the rawmaterials are cheap and convenient to obtain; the preparation method is simple; and the prepared Yuge powder can be used for weight loss, also has a beauty function, and has certain effects of treating patients suffering from hypertension, angina, diabetes, hyperlipidemia and the like.
Owner:SOUTHWEST UNIVERSITY
Novel hydroxysafflor yellow A divalent medicinal salts, and preparing method and uses thereof
The invention provides novel hydroxysafflor yellow A divalent medicinal salt compounds shown as a formula (I), especially a calcium salt of hydroxysafflor yellow A and a magnesium salt of the hydroxysafflor yellow A which are single compounds, and a producing method and medicinal uses of the salt compounds. A natural medicine material safflower is adopted as a raw material. Carthamin yellow is converted into a hydroxysafflor yellow A acid form through a strong-acid H-type cation exchange resin. Then by adjusting a pH value, the hydroxysafflor yellow A is converted into the hydroxysafflor yellow A divalent medicinal salt single compounds. The purity of the compounds can be higher than 98.5%. Compared with the hydroxysafflor yellow A, the compounds are safer, more effective, more stable and more controllable for treatment of blood circulation disturbance diseases such as anti-platelet aggregation, coronary diseases, angina and acute cerebral ischemia, and have better water solubility and human body tolerance. R is defined in the specification.
Owner:ZHEJIANG YONGNING PHARMA
Traditional Chinese medicine preparation for treating coronary heart disease and angina
InactiveCN101332246BCompatibility is simpleSmall doseAnthropod material medical ingredientsCardiovascular disorderSalvia miltiorrhizaMyrrh
The invention relates to a traditional Chinese medicine preparation for curing coronary heart disease and angina which is prepared by the following raw materials according to parts by weight: 18-22 parts of salvia miltiorrhiza, 4-6 parts of Sanchi, 17-23 parts of rubefacient, 13-18 parts of dalbergia wood, 13-18 parts of rhizoma corydalis, 7-11 parts of safflower, 18-22 parts of fleece-flower root, 25-35 parts of caulis spatholobi, 18-22 parts of myrrh, 13-17 parts of ginseng, 13-17 parts of cinnamon, 18-22 parts of epimedium, 4-6 parts of hairy deerhorn, 11-15 parts of glossy ganoderma, 7-9 parts of aweto, 12-18 parts of hemlock parsley, 8-12 parts of peach kernel, 13-17 parts of olibanum, 4-6 parts of scorpion, 4-6 of chilopod, 12-17 parts of the root bark of the peony tree. The preparation has the efficacy of activating Yang and removing obstruction and eliminating phlegm for resuscitation, and is suitable for relieving obstruction of Qi in chest, thoracic pain involving the back, serious pain and tesshin, cough, plenty sputum and breathless , tachycardia. 96 cases of the coronary heat disease are cured by the invention. 85 cases among the 96 cases have obvious effect, while 11cases have no effect. The total effective rate is 88 percent. 87 cases are followed after the medicine is stopped eating for three months, which have no recurrence.
Owner:蔡青
Medicine compounds for treating hypertension, heart disease and angina
InactiveCN101229296AGood effectHydroxy compound active ingredientsMetabolism disorderBorneolMenstruations
The invention discloses a medicine composition for treating hypertension, heart disease and angina pectoris, which compris blood scorpion, pangolin, leech, storax and borneol. The medicine composition for treating hypertension, heart disease and angina pectoris has therapy effects of waking up a patient from unconsciousness, inducing resuscitation, relieving blood status for stagnation, activating blood to promote menstruation, keeping calm and relieving pain, removing pathogenic heat from blood, reducing blood pressure and spasmolysis, and has significant effect in treating various hypertensions, heart diseases and angina pectoris.
Owner:凌泰祥
Pharmaceutical composition for cardiovascular and cerebrovascular diseases and method for preparing the same
InactiveCN101152247AEffective treatmentSuitable for qi stagnation and blood stasis diseaseAnthropod material medical ingredientsCardiovascular disorderCoronary heart diseaseResuscitation
The invention belongs to the medical technical field and discloses a drug combination for the cardiovascular disease and the preparation method of the drug combination. The drug combination contains the pharmacodynamic components of the raw materials of drugs of danshen root, Szechwan lovage rhizome, panax notoginseng, milkvetch root and storax. In order to achieve a better curative effect, a leech, tonka beans and peach nuts can also be added into the drug combination; in order to further improve the curative effect, rosewood, axillary choerospondias fruit and earthworms can be added into the drug combination. The drug combination of the invention has the efficacies of promoting the circulation of qi to induce resuscitation, activating blood circulation for removing blood stasis, dredging channels for alleviating pain etc. and is used for preparing the drugs for remedying the cerebral infarction convalescence of the coronary heart disease, the angina pectoris or the arteriosclerosis, the syndrome of which belong to the qi stagnation and blood stasis with the symptoms of chest pain, oppression in the chest, shortness of breath, heart throb, inefficaciousness of limbs, inarticulacy etc. The drug combination of the invention can be made into any preparation type, which is acceptable in the clinic and the pharmacy, and the oral preparation is preferential.
Owner:吴浩山
Cotinus coggygria compound preparation and use
InactiveCN101485751AGood treatment effectImprove hypoxia toleranceOrganic active ingredientsAntipyreticDiseaseAntithrombotic Agent
The invention relates to a cotinus coggygria scop compound preparation, which is prepared from cotinus coggygria scop, rhizoma corydalis and hawkthorn in proportion, wherein the dosage of the cotinus coggygria scop is equal to that of the hawkthorn, and the dosage of the rhizoma corydalis is not more than 2 / 3 of that of the cotinus coggygria scop or the hawkthorn. The cotinus coggygria scop compound preparation can be used as an anticoagulant and antithrombotic drug, an abirritation drug, a drug for activating blood circulation to dissipate blood stasis and reducing the whole blood viscosity, a drug for improving the organism anti-hypoxia effect, and a drug for treating coronary heart disease or coronarism or miocardial infarction. The cotinus coggygria scop compound preparation not only improves the curative effect of the cotinus coggygria scop, but also reduces the dosage, and is used for easing pain and treating cardiovascular and cerebrovascular disease. Comparative experiments prove that the compound preparation has equivalent anticoagulant activity and abirritation as aspirin, and has the function of organism hypoxia resistance.
Owner:龙丽辉 +1
Five flavored health wine and manufacturing method
InactiveCN101637259ATreatable improvementSignificant excitatory effectNervous disorderMetabolism disorderSpermatorrheaCoronary sclerosis
The invention provides five flavored health wine and a manufacturing method thereof. The five flavored health wine is manufactured by mixing traditional Chinese medicines, rice wine and sugar water; the health wine of invention is characterized by comprising the following traditional Chinese medicines according to parts by weight: 100 parts of schizandra, 90 parts of red ginseng, 80 parts of dwarf lilyturf root, 70 parts of pseudo-ginseng and 60 parts of prepared polygonum multiflorum; the blended weight ratio of the rice wine, five traditional Chinese medicines and sugar water is 69.2:0.8:30. The manufacturing method of the five flavored health wine is as follows: soaking the well-matched traditional Chinese medicines with the rice wine in a porcelain urn for 24 hours; then pouring the boiled sugar water into the urn and sealing for 60 days; waving and oscillating once every day for the first 30 days and placing the porcelain urn in a shade place for the later 30 days; filtering out the medicine residues with three-layer gauze after unsealing and standing for 6 days. The five flavored health wine has efficacies of alleviating or eliminating insomnia and headache, dizziness, heartbeat and spermatorrhea which are caused by neurasthenia, hypertension, coronary sclerosis, angina, impotence, early white hair and whiskers and the like, thus being an ideal health-care product.
Owner:郭生才
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com